Form D — Continuity Biosciences, LLC
0002029079-25-000002 · filed Aug 19, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $12,000,000
- Reported amount sold
- $8,424,490
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Continuity Biosciences, LLC
- CIK
- 2029079
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 8476 LINDRICK LANE
BRADENTON, Florida 34202 - Phone
- 919-480-3892
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ramakrishna Venugopalan · Executive OfficerBradenton, Florida Find on LinkedIn ↗
-
Robert Whitehead · DirectorBradenton, Florida Find on LinkedIn ↗
-
Michael L. Fowler · DirectorBradenton, Florida Find on LinkedIn ↗
-
Monica P. Reed · DirectorBradenton, Florida Find on LinkedIn ↗
-
Allen R. Weiss · DirectorBradenton, Florida Find on LinkedIn ↗
-
Josephine Torrente · DirectorBradenton, Florida Find on LinkedIn ↗
-
Joseph DeSimone · DirectorBradenton, Florida Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗